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a  b  s  t  r  a  c  t
Evolution  is a  key  aspect  of  the biology  of many  pathogens,  driving  processes  ranging  from  immune  escape
to  changes  in virulence.  Because  evolution  is inherently  subject  to  feedbacks,  and  because  pathogen  evo-
lution  plays  out  at scales  ranging  from  within-host  to  between-host  and  beyond,  evolutionary  questions
provide  special  challenges  to the  modelling  community.  In this  article,  we  provide  an  overview  of  ﬁve
challenges  in  modelling  the evolution  of pathogens  and their  hosts,  and  point  to  areas  for  development,
focussing  in  particular  on the  issue  of  linking  theory  and  data.
© 2014  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Evolution is the change in gene frequencies resulting from
selection (where genes with greater reproductive contributions to
future generations spread within populations), mutation, recom-
bination or re-assortment (where genetic material is exchanged
between chromosomes), or drift. Evolution plays an important
role in the dynamics of many infectious diseases. Vaccine escape
in inﬂuenza, drug-resistance in HIV, and virulence evolution
in Marek’s disease are all examples of evolutionary processes.
Developing models that accurately describe pathogen evolution
is inherently challenging because of the complexity of pathogen
life cycles and the difﬁculty in characterizing the (dynamic) ﬁtness
landscapes driving pathogen evolution. Ultimately, the pathogen’s
genotype, together with the characteristics of the host, determines
both how disease is caused and how much of the pathogen is emit-
ted by the host. Once emitted, pathogens must infect new hosts.
How much transmission is realized also depends on the physical
environment, the host’s behaviour and population structure, as
well as the distribution of the disease in the population. To under-
stand pathogen evolution we need to integrate from the genotype,
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and span these levels, encompassing stochastic processes such as
transmission bottlenecks (see Gog et al., 2015). This requires the
integration of knowledge from various ﬁelds: molecular biology,
microbiology, medicine and epidemiology to name a few (Fig. 1).
Here, we  outline ﬁve challenges of modelling evolution that
reﬂect this interaction across scales. We  start by detailing the most
basic and general challenge of all, that of characterizing ﬁtness.
Next, we  address challenges for modelling how pathogens shape
each other’s evolution (coinfection) and the related topic of how
pathogens shape host immune diversity; and the classic evolu-
tionary problem of what forces allow maintenance of pathogen
diversity (coexistence). Finally, we  discuss how modelling can help
us understand how mechanisms of pathogen replication inﬂuence
the generation of genetic variation, upon which selection acts.
1. Deﬁning and measuring ﬁtness for pathogens across
scales
If we know how ﬁtness changes with changes in the genes in
the pathogen, and how it does so across scales (Fig. 1), we can
make informed statements about selection and adaptation. Fitness
is generally deﬁned as the reproductive contribution of an individ-
ual to the next generation, in a particular environment. Pathogens
will experience different such environments over the course of
an infection: for instance, they will have to overcome the host’s
http://dx.doi.org/10.1016/j.epidem.2014.12.003
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Fig. 1. The scales of infectious disease dynamics and evolution. Diverse research ﬁelds address overlapping levels of this hierarchy. Genetics, cell biology, microbiology occur at
the  smallest scales, but have projections to larger scales; e.g. genetics also contributes to interpreting population level outcomes. Pharmacology, immunology and physiology
occur  primarily at the whole organism level, but comprise processes at smaller scales and often have impacts at larger scales (e.g. herd immunity). Community ecology and
epidemiology arguably are relevant at each scale, with community ecology relevant both for understanding multiple host species but also gut microbiota dynamics, and
epidemiological principles describing dynamics in populations from cells to hosts.
defences, colonize the host, withstand attacks of the immune sys-
tem, and accomplish transmission and infection. The components
of ﬁtness can vary over such a cycle (and indeed the cycle often
involves numerous pathogen generations), and to calculate ﬁtness,
an appropriate average has to be taken over this path, integrating
information across various scales.
Although deﬁning ﬁtness of pathogens is straightforward in
principle, linking this deﬁnition to attainable data in order to
quantify ﬁtness is not. Researchers have typically broken the evo-
lutionary cycle apart to focus on particular levels of selection – for
example, distinguishing within-host ﬁtness (describing the growth
of the pathogen population within an infected individual) and
between-host ﬁtness (describing transmission of infection to new
host individuals). This has the beneﬁt of corresponding to clear
biological differences, as well as quantities that can be measured
(although the path to linking processes across scales to ﬁtness is not
obvious). However, even with the process broken down into more
manageable parts, there are still considerable barriers to deﬁning
scale-speciﬁc ﬁtness components (see Challenge 2 in Gog et al.,
2015) for more complexities related to within-host ﬁtness), and
there is no general relationship between ﬁtness at the within-host
scale and the number of new hosts infected (Park et al., 2013).
The challenges inherent to even the (apparently contained)
problem of measurement of the reproduction of individual
pathogens within-host have led to the development of a range
of in vitro systems designed to quantify variation in rates of
pathogen replication in different contexts. Inevitably, these esti-
mated pathogen replication rates reﬂect only one aspect of ﬁtness
at an in vivo scale. Key modelling challenges include providing
further innovations in linking in vitro data-streams to in vivo mea-
surements of aspects of ﬁtness, such as viral titre kinetics or the
outcome of competition assays (Huijben et al., 2013) (see also
Challenge 7, Frost et al., 2015), and accounting for the fact that
the genotype to phenotype to ﬁtness map  is likely to be context-
dependent, and the within-host ﬁtness landscape may  change (see
also Challenge 3, Gog et al. (2015); and Challenge 6, Frost et al.
(2015), on the challenges of developing genotype to phenotype
maps). In particular, the ﬁtness of a genotype will often depend
on the frequency of all other genotypes, as a result of immune sys-
tem activity. Machine-learning and modelling approaches can be
used to bridge the in vitro and in vivo levels (Kouyos et al., 2011),
but given the nature of the underlying in vitro data such approaches
currently neglect crucial within-host ﬁtness determinants such as
the immune system. This poses the challenge of ﬁnding novel ways
to parameterize the activity of the host’s immune system from
data (e.g., Metcalf et al., 2011) and incorporate it into the mod-
els for pathogen ﬁtness, and the associated (and shifting) ﬁtness
landscapes.
Beyond the individual host, other instances of population struc-
ture (e.g., age groups or host species) may inﬂuence pathogen
evolution. If these host classes additionally compete or otherwise
interact, this will affect the pathogen’s evolution, and any evo-
lutionary outcomes are likely to depend on the details of this
interaction. The next generation matrix approach is useful for these
types of systems (Diekmann et al., 2010), as are approaches that
renormalize the system to describe group-level reproduction (Ball
et al., 1997), but few general mathematical principles are known,
and furthermore, parameterizing such models given available data
remains challenging (Funk et al., 2013) (see also Buhnerkempe
et al., 2015).
Bringing together all these various threads to estimate an all-
encompassing ﬁtness value for any particular pathogen genotype
is a major challenge, and would be even if all the data were avail-
able. Even though conceptual and mathematical frameworks for
dealing with such multi-scale processes have been developed (Park
et al., 2013; Lion et al., 2011), such calculations can be extremely
cumbersome, and their interpretation complex, particularly when
evolution operates at different scales, as is the case for pathogens.
2. Developing models to capture the impact of co-infection
on the evolutionary process
For many pathogens, infection by multiple strains or other
pathogens may  have little or no epidemiological impact – the key
distinction is simply whether a host is infected, or not (as for
measles, for instance). However, there are pathogens for which
coinfection alters pathogen dynamics, and this can have two major
impacts on evolutionary processes. First, coinfection can lead to
genetic exchange between co-infecting pathogens (especially for
viruses and bacteria) that may be essential to immune escape, or
host jumps. Such exchanges may  occur both among pathogens
of the same species (e.g. homologous recombination) or among
pathogens of different species (transformation, transduction, con-
jugation) (see Challenge 5, Frost et al. (2015) for more details).
Second, coinfection may  be associated with within-host compe-
tition (e.g., mouse malaria parasites may  compete for red blood
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cells), or facilitation (e.g., helminth mediated immune-suppression
might increase microparasite within-host growth rates; Viney and
Graham, 2013), both of which can alter ﬁtness, and thus evolution-
ary outcomes. The resulting dynamics are analogous to individuals
competing within metapopulations, and can be formulated the-
oretically using kin selection or multilevel selection formalisms
(Lion et al., 2011), and these models can be extended to encom-
pass within-patch dynamics (Jansen and Vitalis, 2007). However,
such methods assume known costs and beneﬁts to the interaction
between competing coinfecting pathogens. This implies develop-
ing adequate within-host models, a tremendous challenge given
sparse data on the complex nature of pathogen–pathogen interac-
tions, as mediated by immune response, resource competition and
treatment (see also Gog et al., 2015). Where sufﬁcient elements of
the biology are known, but the speciﬁcs of coinfection interactions
remain unclear, models can be deployed to explore the outcomes of
different interactions in terms of measurable quantities to identify
key mechanisms (Mideo et al., 2011). These frameworks can then
be used to prioritize experimental directions that inform expected
evolutionary trajectories. A key area for research of this kind is
on how drug resistance spreads in the face of different treatment
regimes in the context of co-infection (Huijben et al., 2013; Kouyos
et al., 2014).
Theoretical challenges also remain: for some co-infecting
pathogens, the order of infection can affect prognosis, and whether
infections are sequential, co-transmitted, or super-infecting can
change dynamics (see also Challenge 5, Gog et al., 2015). While
incorporating such effects into models can be straightforward,
realistically describing interdependent processes such as immuno-
suppression or cross-reactive immunity can be complicated.
Modelling evolution under coinfection presents a special theoret-
ical challenge for bacterial communities, because of the genetic
exchange between species through mobile genetic elements such
as plasmids and phages (see also below, Challenge 5). The develop-
ment of models that can capture community assembly, invasibility,
competition, and immune interactions within the bacterial micro-
biome may  be an especially rich area for modelling, in particular
with reference to exploiting the potential of meta-genomic and
meta-transcriptomic data. Very few models have considered, e.g.,
the dynamics of traits within a community of pathogens that are
exchanging genetic material (see Morton et al., 2014; San Millan
et al., 2013).
3. Modelling how pathogen characteristics shape the
evolution of host immune diversity
Host–parasite interactions reﬂect an inherently co-evolutionary
process. Despite this, the research focus to date has been some-
what one-sided. Models of selection pressures on the parasite (e.g.,
evolution of virulence, etc.) are widespread (Alizon et al., 2009).
Research into the host’s potential for coevolution (Little et al., 2010)
in terms of diversity of immune responses also has a relatively long
history (e.g., Borghans et al., 2004). However, key features of host
biology such as immunopathology (Day et al., 2007), host variability
in tolerance (Best et al., 2008) or in susceptibility (Boots et al., 2012),
and structure across host immune recognition loci (Penman et al.,
2013) are just starting to be considered. This bias reﬂects in part
the difference of time-scales in operation – parasites’ generation
times are generally so much shorter than hosts’ that a focus on par-
asite evolution alone seems justiﬁed. A key challenge is identifying
when, or for what host traits, this assumption is no longer valid;
and subsequently, identifying what parasite community features
select for particular host responses. For example, what pathogen
characteristics might select for a “dangerous” immune response,
i.e., over-investment and risk of immune pathology?
There is also considerable opportunity to develop models that
explore the mechanistic basis for results obtained in comparative
immunology studies; e.g., correlations between promiscuity and
white blood cell counts across primates (Nunn et al., 2000). Macro-
evolutionary forces operating at broad scales and long timescales
that act to shape host features will affect within-host dynamics, in
particular those linked to aspects such as immunopathology. The
role of feedbacks in this process is another very interesting ques-
tion for which modelling might provide insights. For example, if
changes in host ecology shift host longevity, this is likely to alter
selection on pathogen virulence (assuming some form of virulence-
transmission trade-off), which might then feed back onto altering
selection on host longevity.
4. Understanding maintenance of pathogen diversity
A range of mechanisms can maintain pathogen diversity
(Grenfell et al., 2004). At the most basic level, neutral processes can
maintain diversity, via a balance of mutation (creating diversity)
and genetic drift (destroying diversity). Selective mechanisms will
also play a role, with life-history trade-offs (e.g. between within-
host replication and transmissibility) allowing stable coexistence;
and temporal and spatial ﬂuctuations in selection allowing tem-
poral or spatial niche separation and coexistence. For example,
antibiotic consumption varies across individuals, age-classes, insti-
tutions (hospital versus community), regions and countries (Cars
et al., 2001), which creates a mosaic of selective pressures that may
allow coexistence of resistant and sensitive strains. Similarly, selec-
tion for antigenic escape varies as a function of differences in host
genetics or exposure history (previous infections and vaccinations).
A key challenge is determining the relative contribution of neu-
tral and selective mechanisms. For example, the diversity of HIV-1
has been regarded primarily as a result of the demography and
geography of viral spread (Grenfell et al., 2004). However, several
studies have also found adaptive substitutions in HIV-1 in particular
populations of humans (Kawashima et al., 2009) and it is currently
unclear whether selective or neutral processes dominate in shaping
the diversity of HIV-1. Similarly, Cobey and Lipsitch (2012) argued
that the diversity of Streptococcus pneumoniae can be explained by
the interplay of niche and neutral effects. Building on these types
of analyses to encompass a broader array of pathogens is a key
direction for future research.
Another complication is that selective pressure may  vary across
scales (e.g., from within-host to between-host, see Challenge 1),
but which scale is key to maintenance of diversity remains poorly
resolved for most pathogens. For example, many bacterial species
(such as Staphylococcus aureus) colonize different anatomical sites,
which may  impose different selective requirements (Klein et al.,
2009). Assessing the impact of this within-patient heterogene-
ity at the population level requires understanding the cross-scale
dynamics of these pathogens, and models have a key role to play in
linking the relevant mechanisms. Similarly, it has been argued for
HIV that selection at the within-host and between host-level act
in opposite directions (Lythgoe et al., 2013). Such a trade-off can
help to maintain diversity, but the actual quantitative contribution
of this mechanism remains to be determined.
Mathematical models have made a range of important predic-
tions about the determinants of pathogen diversity. Much of the
current concern about the wide spread use of antibiotics, and sub-
sequent emergence or spread of resistance are at least implicitly
based on evolutionary models. Likewise, the evolutionary conse-
quences of imperfect vaccines were, at ﬁrst, theoretical prediction
(Gandon et al., 2001). More speciﬁc questions have also been
tackled – such as how the strain distribution of S. pneumoniae
responds to vaccination (Cobey and Lipsitch, 2012; Bottomley et al.,
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2013), or the potential for coexistence of drug resistant and drug-
sensitive strains in speciﬁc settings (Kouyos et al., 2013). The
challenging goal of making more detailed predictions relating to
how much and when evolution will take place will require integrat-
ing the increasingly available data on selective forces (antibiotic
consumption, host genetic variation, exposure to pathogens) and
host demography into epidemiological models. Quantitative pre-
dictive models will also require much better estimates of pathogen
ﬁtness (see Challenge 1, especially with the application of in vitro
systems to in vivo inference) and mutational pathways, with par-
ticular focus on compensatory mutations, ﬁtness at different levels
(within-host vs. transmission, see Challenge 1), and the interplay
of selective and stochastic effects.
Finally, for some pathogens it is unclear why  diversity is not
larger than observed (HIV at the within-host scale, inﬂuenza at the
population scale (Grenfell et al., 2004)). Modelling studies can play
an important role in proposing mechanisms to explain this pattern
(Koelle et al., 2006), which can spur targeted empirical work to test
these hypotheses.
5. Developing better models for the impact of genetic
systems on pathogen evolution
The operation of inheritance in bacteria is highly complex.
Unrelated individuals may  exchange DNA (‘horizontal gene trans-
fer’) and many individuals carry plasmids (DNA that is physically
separate of the organisms’ genomic DNA, and can be replicated
independently from it) that can often carry key genes such as those
linked to antibiotic resistance. The environment that a gene will
have experienced in its evolutionary past will depend on the route
through which it is passed on: a gene on a plasmid will have been
in different organisms and environments than a gene on a chromo-
some. Therefore the ﬁtness, and selective forces on a gene depend
on the details of the genetics. For many pathogens (viruses, as well
as bacteria, etc.) related complexities emerge from the process of
recombination (see Frost et al. (2015) for more details). A challenge
here is to develop models not just of individual pathogens, but
also of individual genes, which take the genetic architecture into
account.
Even for the comparatively straightforward process of mutation,
the basic biology of pathogen replication can inﬂuence evolutionary
dynamics strongly. The molecular- and cellular-scale mechanisms
by which pathogens replicate their genomes and create new infec-
tious particles are subjects of intensive study in microbiology and
virology, but have been largely ignored in dynamic models of
pathogen evolution. Recent theoretical models have shown that
the within-host emergence of new viral strains is strongly affected
by whether offspring virions are released via budding or bursting
(Pearson et al., 2011), by different mechanisms of genome repli-
cation (Loverdo et al., 2012), and by how genomes and proteins
are mixed in virion assembly (Loverdo and Lloyd-Smith, 2013b).
One important challenge is to test and expand this developing
body of theory by comparison with experimental data, particu-
larly given new opportunities arising from deep sequencing data.
Current models have only scratched the surface of microbiolog-
ical knowledge, so there is scope to include many more details
– one key task for modellers will be to determine if, when, and
how these details impact evolutionary processes at higher scales,
and to assess whether the cost in additional model complexity is
worth bearing. For instance, recent progress on modelling viral
replication mechanisms (e.g. Sardanyés et al., 2012) opens inter-
esting opportunities for cross-scale modelling to explore potential
impacts on evolutionary dynamics. Do certain replication mecha-
nisms confer greater phenotypic robustness to mutations, or higher
propensity for adaptive evolution? Alternatively, could the details
of pathogen replication present unrecognized barriers to adapta-
tion such as the delayed expression of beneﬁcial phenotypes (e.g.
Loverdo and Lloyd-Smith, 2013b)? Conversely, better models of
genome replication and viral packaging will advance the important
goal of achieving better estimates of viral mutation rates (Thébaud
et al., 2010).
A better understanding of the genetic systems of pathogens will
be crucial for our understanding of how pathogen populations can
move on ﬁtness landscapes (see Challenge 1). For example ﬁtness
valleys can represent a barrier to adaptation at low mutation rates
(Levin et al., 2000) but not at high mutation rates. Similarly the
probability of evolutionary rescue of pathogen populations (e.g. in
the context of antimicrobial therapy or vaccination) may  depend
crucially on mutation rates (Kirkpatrick and Peischl, 2013; Loverdo
and Lloyd-Smith, 2013a).
Conclusion
Many of the challenges in modelling pathogen evolution that we
introduced here revolve around questions of quantifying ﬁtness.
We focused particularly on biological complexities and uncertain-
ties, the impact of coinfection, and evolutionary mechanisms that
create and shape diversity in hosts and pathogens. However, the
effects of evolution on pathogen dynamics are vast, and potential
modelling challenges reﬂect this. Other papers within this Special
Issue tackle questions arising in the context of emergence of novel
pathogens (Lloyd-Smith et al., 2015), vaccine escape (Metcalf et al.,
2015), or in extending the use of phylodynamics (Frost et al., 2015).
Progress in tackling these challenges has the potential to contribute
to a broad array of highly applied questions, including management
of drug resistance, improvement of clinical care, and reconciling
individual and population goals for public health in the context of
pathogen evolution.
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